- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05016570
The Impact of Picture Narrative Format on Print Lung Screening Communication Outcomes
The Impact of Picture Narrative Format on Knowledge and Acceptability for Lung Screening Print Decision Support Materials
Study Overview
Status
Conditions
Detailed Description
Population screening is key to detecting lung cancer early at a more treatable stage. Uptake of screening should be equitable (i.e., screening benefits all eligible members of the population and does not contribute further to health disparities) and informed (i.e., participants have been involved in the decision to take part and their decision aligns with their values and circumstances). Print decision support materials are the primary mechanism for encouraging engagement with cancer screening and supporting decision making. It is essential that we identify print communication techniques that are effective in informing invitees about lung screening.
The intervention, picture narrative information about lung screening, was previously developed through codesign and prototype testing with people likely to be eligible for lung screening (50 to 75 years old, past or current heavy smokers). Participants will be randomised to one of three groups: Picture narrative format, Text with pictures (control 1) or, Text-only (control 2). This study will assess whether presenting lung screening information in a picture narrative format can improve lung cancer screening knowledge, eligibility self-assessment and attitudes. It will also assess whether perceptions of the information designs can explain any impact of the intervention on these outcomes and whether there are differences across socioeconomic groups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Glasgow, United Kingdom, G12 0XH
- Mental Health and Wellbeing, University of Glasgow
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Living in Glasgow
- Willing and able to respond unaided to invitation to participate in the trial and give informed consent.
- Aged between 49 and 75 years
Exclusion Criteria:
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Picture narrative lung screening information
Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format which uses text in combination with sequences of pictures to communicate a coherent message.
The designs follow conventions from comics/graphic narratives and key stakeholders were involved during the design process.
|
Lung screening information formatted as picture narratives
|
|
Active Comparator: Text with pictures lung screening information
Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text with non-narrative pictures for decoration.
The pictures have been extracted from the picture narratives being used Arm 1.
|
Lung screening information formatted as text and non-narrative pictures
|
|
Active Comparator: Text-only lung screening information
Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text and no pictures.
|
Lung screening information formatted as text with no pictures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Lung Cancer Screening Knowledge scores
Time Frame: Immediately post-intervention
|
Participants will be asked 6 multiple choice questions related to the lung screening information presented to the participants during the intervention, covering; Procedure, Eligibility - who, Eligibility - why, Benefits, Adverse effects, Potential results.
|
Immediately post-intervention
|
|
Lung Cancer Screening Eligibility self-assessment
Time Frame: Immediately post-intervention
|
Concordance between self-reported personal eligibility for lung cancer screening and actual eligibility based on self-reported age and smoking behaviour.
|
Immediately post-intervention
|
|
Participant Lung Cancer Screening Attitudes
Time Frame: Immediately post-intervention
|
Self-administered four-item lung cancer screening attitudes measure covering cancer fear, fatalism, benefits, and worry, previously used by Smits et al 2018.
|
Immediately post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Design appraisal ratings
Time Frame: Immediately post-intervention
|
Self-administered nine-item measure rating perceptions of appeal, enjoyment, interest, ease of use, trustworthiness, appropriateness, helpfulness, informativity. Alongside a single item asking participants whether enough information was provided. |
Immediately post-intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment compliance
Time Frame: Immediately post-intervention
|
Self-reported length of time spent reading the lung screening information.
|
Immediately post-intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kathryn Robb, PhD, University of Glasgow
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 200200021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Screening
-
Pamukkale UniversityThe Scientific and Technological Research Council of TurkeyActive, not recruitingCancer Screening | Men's Health ScreeningTurkey (Türkiye)
-
Harvard School of Public Health (HSPH)National Cancer Institute (NCI); Massachusetts League of Community Health Centers and other collaboratorsNot yet recruitingTobacco Cessation | Cervical Cancer Screening | Breast Cancer Screening | Colon Cancer Screening
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI)Completed
-
Johns Hopkins UniversityState of MarylandCompleted
-
Lanxi Hospital of Traditional Chinese MedicineZhejiang Cancer Hospital; Zhejiang Chinese Medical UniversityWithdrawn
-
NYU Langone HealthCenters for Disease Control and PreventionRecruitingCancer ScreeningUnited States
-
Sun Yat-sen UniversityUnknown
-
Stanford UniversityHeidelberg Institute of Global Health, Heidelberg University, GermanyNot yet recruitingColorectal Cancer ScreeningUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)Recruiting
-
University of RochesterRecruiting
Clinical Trials on Picture narrative information format
-
University of North Carolina, Chapel HillDuke University; Agency for Healthcare Research and Quality (AHRQ)CompletedColorectal Cancer | Prostate Cancer | Osteoporosis | Preventive ScreeningUnited States
-
Zealand University HospitalDemensAI ApS (private tech partner, Denmark)Not yet recruitingStress | Cognitive Impairment | Mild Cognitive Impairment (MCI) | Lewy Body Dementia (LBD) | Frontotemporal Dementia (FTD) | Alzheimer Dementia (AD) | Depression - Major Depressive Disorder | Vascular Dementia (VaD) | Dementia (Diagnosis)Denmark
-
Arizona State UniversityNational Cancer Institute (NCI); Mayo ClinicCompletedDepression | Stress | Anxiety | Hematopoietic Stem Cell Transplantation | Bone Marrow Transplant | Information Disclosure | Psychosocial Health | NarrativeUnited States
-
Carnegie Mellon UniversityCompleted